US Stock MarketDetailed Quotes
PRFX PainReform
- 3.6892
- -0.4708-11.32%
Trading Nov 21 10:26 ET
2.18MMarket Cap-25P/E (TTM)
3.9000High3.3000Low146.12KVolume3.3100Open4.1600Pre Close533.89KTurnover24.74%Turnover RatioLossP/E (Static)590.62KShares80.640052wk High-1.07P/B2.18MFloat Cap1.727252wk Low--Dividend TTM590.62KShs Float1884.0000Historical High--Div YieldTTM14.42%Amplitude1.7240Historical Low3.6530Avg Price1Lot Size
About PainReform Company
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
Company Profile
SymbolPRFX
Company NamePainReform
Listing DateSep 1, 2020
Founded2007
CEOMr. Ilan Hadar
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address65 Yigal Alon Street
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6744316
Phone972-3-717-7050
Websitehttp://www.painreform.com
Company Executives
- Name
- Position
- Salary
- Ilan Hadar
- Chief Executive Officer and Chief Financial Officer
- 563.00K
- Professor Eli Hazum
- Director and Chief Technology Officer
- 270.00K
- Dr. Sigal Aviel
- Chief Operating Officer
- 351.00K
- Rita Keynan
- Vice President, Pharmaceutical Operations
- 353.00K
- Dr. Ehud Geller
- Chairman of the Board
- 276.00K
- Dr. Ellen S. Baron
- Independent Director
- --
- Efi Cohen-Arazi
- Independent Director
- --
- Augustine J. Lawlor
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data